Eravacycline for Mycobacterium abscessus infections: pharmacodynamic advantages of long-acting post-antibiotic effects and weekly dosing regimens

ABSTRACT Mycobacterium abscessus (MAB) is one of the most common non-tuberculous mycobacteria with an extremely high resistance rate to classic anti-tuberculosis drugs. This study aimed to evaluate the activities of the novel tetracycline agent eravacycline (ERC) against MAB using clinical isolates...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Microbiology Spectrum
المؤلفون الرئيسيون: Ruoyan Ying, Guoling Yang, Xiaochen Huang, Jie Wang, Li Wang, Wei Sha
التنسيق: مقال
اللغة:الإنجليزية
منشور في: American Society for Microbiology 2026-05-01
الموضوعات:
Mycobacterium abscessus
eravacycline
PAE
PA-SME
pulmonary infection
الوصول للمادة أونلاين:https://journals.asm.org/doi/10.1128/spectrum.01473-25

الانترنت

https://journals.asm.org/doi/10.1128/spectrum.01473-25

مواد مشابهة